Andreas Halvorsen - Viking Global Investors
Holding/activity history for Celldex Therapeutics Inc New (CLDX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | 0 | 0.00 | Sell 100.00% | 0.29 | SEC | ||
| 2022 Q2 | 2,337,854 | 0.29 | Add 26.60% | 0.06 | $26.96 | $63,029,000 | SEC |
| 2022 Q1 | 1,846,647 | 0.26 | Add 143.66% | 0.15 | $34.06 | $62,897,000 | SEC |
| 2021 Q4 | 757,881 | 0.08 | Reduce 0.58% | <0.01 | $38.64 | $29,285,000 | SEC |
| 2021 Q3 | 762,296 | 0.11 | Buy | 0.11 | $53.99 | $41,156,000 | SEC |